COMMUNIQUÉS West-GlobeNewswire

CohBar to Announce 2018 Third Quarter Financial Results and Host Conference Call on November 14, 2018

31/10/2018 - 14:00

MENLO PARK, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today [...]

OncBioMune CEO Dr. Jonathan Head Speaking at 2018 Global Summit on Genitourinary Malignancies

31/10/2018 - 14:00

BATON ROUGE, La., Oct. 31, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Innovate Biopharmaceuticals Announces Participation at the Jefferies 2018 London Healthcare Conference

31/10/2018 - 14:00

RALEIGH, N.C., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and [...]

Strongbridge Biopharma plc Reports Third Quarter 2018 Financial Results and Provides Corporate Update

31/10/2018 - 13:47

~ Financial Position to be Significantly Strengthened in Fourth Quarter 2018 by $145 Million of Upfront Cash and $36.7 Million Equity Investment from Separately Announced Transactions with Novo Nordisk; Company Intends [...]

Golden Leaf Holdings to Hold Conference Call to Review Third Quarter 2018 Results

31/10/2018 - 13:45

PORTLAND, Ore., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]

Strongbridge Biopharma plc Enters into Agreement for Novo Nordisk to Acquire the U.S. and Canadian Rights to MACRILEN™ (macimorelin)

31/10/2018 - 13:45

~ Strongbridge to Receive Upfront Payment of $145 Million and Tiered Royalty Stream from Novo Nordisk ~ ~ Novo Nordisk to Purchase Approximately 5.2 Million Ordinary Shares of Strongbridge Biopharma plc at Purchase [...]

Marrone Bio Innovations to Report Third Quarter 2018 Financial Results on Tuesday, November 13th at 4:30 p.m. Eastern Time

31/10/2018 - 13:31

DAVIS, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, will release financial results for [...]

Laura Clague Named to Fluidigm Board of Directors

31/10/2018 - 13:30

Senior Financial Leader with Broad Corporate and Biotech Expertise SOUTH SAN FRANCISCO, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Laura M. Clague to [...]

Arbutus to Report Third Quarter 2018 Financial Results

31/10/2018 - 13:30

WARMINSTER, Pa., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its third [...]

Tower One October Update

31/10/2018 - 13:30

VANCOUVER, British Columbia, Oct. 31, 2018 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces it has begun the construction of 16 towers in [...]

Director/PDMR Shareholding

31/10/2018 - 13:15

DXS INTERNATIONAL PLC Director Dealing The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that [...]

Catalyst Pharmaceuticals to Hold Third Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, November 8th, 2018

31/10/2018 - 13:03

CORAL GABLES, Fla., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]

Nexstim Plc: Invitation to the Extraordinary General Meeting

31/10/2018 - 13:02

Company announcement, Helsinki, 31 October 2018 at 2:00 PM Nexstim Plc: Invitation to the Extraordinary General Meeting Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing [...]

Nuvectra® to Participate in Two Upcoming Investor Conferences

31/10/2018 - 13:01

PLANO, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief [...]

Study: Liberals and news junkies on edge as midterms approach

31/10/2018 - 13:00

Left-leaning politics, frequent news consumption tied to greater anxiety symptoms SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- With the midterm elections less than a week away, anxiety in America is running high. [...]

CASMED Reports Third-Quarter 2018 Financial Results

31/10/2018 - 13:00

FORE-SIGHT® sales increase 20%; sensor sales up 22% on 20% growth in the U.S.; operating loss narrows by 25% Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) -- CAS [...]

Chembio to Report Third Quarter 2018 Financial Results on November 8, 2018

31/10/2018 - 13:00

MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial [...]

Sun BioPharma, Inc. Announces Leadership Changes

31/10/2018 - 13:00

David B. Kaysen Steps Down as President, CEO and Board Member Effective October 31, 2018 Michael T. Cullen MD, MBA, Executive Chairman, Elected President and CEO by Board of Directors Effective October 31, 2018 [...]

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

31/10/2018 - 13:00

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop, will present at the [...]